, Tracking Stock Market Picks
Enter Symbol:
Rating: SEM
Positive $11

Susquehanna Financial rated Select Medical Corporation (AMEX: SEM) to Positive with price target $11

Tuesday,  Mar 23, 2010  8:25 AM ET by Kristen Bailey

Susquehanna Financial rated Select Medical Corporation
(AMEX: SEM) to Positive with price target $11 with today's price of $8.75.

Select Medical Holdings Corporation is an operator of both specialty hospitals and outpatient rehabilitation clinics in the United States. As of June 30, 2009, the Company operated 87 long-term acute care hospitals and five inpatient rehabilitation facilities in 25 states, and 948 outpatient rehabilitation clinics in 37 states and the District of Columbia. The Company operates two business segments: specialty hospital and outpatient rehabilitation segments, which accounted for approximately 69% and 31%, respectively, of its net operating revenues during the year ended December 31, 2008. Its specialty hospital segment consists of hospitals designed to serve the needs of long-term stay acute patients and hospitals designed to serve patients who require intensive inpatient medical rehabilitation. Its outpatient rehabilitation business consists of clinics and contract services that provide physical, occupational and speech rehabilitation services.

Since its inception in 1987, the Susquehanna International Group of Companies (SIG)* has grown from a trading firm on the Philadelphia Stock Exchange to one of the largest privately held financial institutions in the world. With more than 1,500 employees worldwide, SIG sits at the helm of the latest trends and developments in trading and market making, institutional sales, research, private equity, venture capital, and investment banking. SIG has offices across North America, Europe, Asia, and Australia. SIG distinguishes itself through its global market presence, capital commitment, and its grasp of trading dynamics. It excels at decision theory and implementing sophisticated pricing probability models.

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy